IP Verse

Sumitomo Dainippon Pharma competitive analysis

Latest publications and patents of Sumitomo Dainippon Pharma New

Explore the latest publications and patents granted to Sumitomo Dainippon Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 24, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Sumitomo Dainippon Pharma
EP3656852	Sep 3, 2025	Method For Maturation Of Retinal Tissue Containing Continuous Epithelium	Granted And Under Opposition

Latest PTAB cases involving Sumitomo Dainippon Pharma

Discover the latest PTAB cases involving Sumitomo Dainippon Pharma, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 30, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Sumitomo Dainippon Pharma
IPR2020-01053	Jun 5, 2020	SLAYBACK PHARMA	SUMITOMO DAINIPPON PHARMA	Terminated
IPR2017-01292	Apr 18, 2017	PAR PHARMACEUTICAL	SUMITOMO DAINIPPON PHARMA	Terminated-Settled

Peer Comparison New

IP litigation analysis comparing Sumitomo Dainippon Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
SUMITOMO DAINIPPON PHARMA	-	-	-	2	Non-Active
PAR PHARMACEUTICAL	-	-	21	-	Highly Aggressive
SLAYBACK PHARMA	-	-	3	-	Highly Aggressive